Expanding Therapeutic Options for Breast Cancer

home / peer-exchange / breast-cancer-expanding-options
Therapy Approaches in HR+ Breast Cancer

EP. 1: Therapy Approaches in HR+ Breast Cancer

July 12th 2018
Frontline Therapy in HR-Positive Breast Cancer

EP. 2: Frontline Therapy in HR-Positive Breast Cancer

July 12th 2018
HR-Positive Breast Cancer: Predictive Biomarkers

EP. 3: HR-Positive Breast Cancer: Predictive Biomarkers

July 12th 2018
Sequencing and Role of Everolimus in HR-Positive Breast Cancer

EP. 4: Sequencing and Role of Everolimus in HR-Positive Breast Cancer

July 12th 2018
Clinical Rationale for PI3K Inhibitors in BC

EP. 5: Clinical Rationale for PI3K Inhibitors in BC

July 12th 2018
Treating gBRCA1/2-Mutated HR+ Breast Cancer

EP. 6: Treating gBRCA1/2-Mutated HR+ Breast Cancer

July 12th 2018
Patient Selection for Adjuvant Therapy in EBC

EP. 7: Patient Selection for Adjuvant Therapy in EBC

July 12th 2018
Role of Adjuvant Denosumab in Early Breast Cancer

EP. 8: Role of Adjuvant Denosumab in Early Breast Cancer

July 12th 2018
Clinical Data on Extended Adjuvant Therapy in HR+ BC

EP. 9: Clinical Data on Extended Adjuvant Therapy in HR+ BC

July 12th 2018
Chemotherapy and PARP Inhibitors in BC

EP. 10: Chemotherapy and PARP Inhibitors in BC

July 12th 2018
ADCs & Checkpoint Inhibitor Combinations in TNBC

EP. 11: ADCs & Checkpoint Inhibitor Combinations in TNBC

July 12th 2018
Other Novel Targets and Future Outlook in Breast Cancer

EP. 12: Other Novel Targets and Future Outlook in Breast Cancer

July 12th 2018